Soleno Therapeutics (SLNO)

• Market cap: $2.56B
• 1 day: -3.03%
• 5 days: -1.93%
• 1 month: -3.83%
• 3 months: -26.65%
• 6 months: -43.29%
• Year to date: 4.24%
• 1 year: 1.23%
• 5 years: 66.32%
• 10 years: -68.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152